Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP134432.RAU6tza2332yk-VPGBp6ZmoXcLQ0tMd-myhwhfF_sq5nE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP134432.RAU6tza2332yk-VPGBp6ZmoXcLQ0tMd-myhwhfF_sq5nE130_assertion type Assertion NP134432.RAU6tza2332yk-VPGBp6ZmoXcLQ0tMd-myhwhfF_sq5nE130_head.
- NP134432.RAU6tza2332yk-VPGBp6ZmoXcLQ0tMd-myhwhfF_sq5nE130_assertion description "[plasmas from patients with aPL antibodies with thromboembolism reduce both A5 binding to phospholipid and A5 anticoagulant activity, identifying a novel mechanism for thrombosis in the aPL syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP134432.RAU6tza2332yk-VPGBp6ZmoXcLQ0tMd-myhwhfF_sq5nE130_provenance.
- NP134432.RAU6tza2332yk-VPGBp6ZmoXcLQ0tMd-myhwhfF_sq5nE130_assertion evidence source_evidence_literature NP134432.RAU6tza2332yk-VPGBp6ZmoXcLQ0tMd-myhwhfF_sq5nE130_provenance.
- NP134432.RAU6tza2332yk-VPGBp6ZmoXcLQ0tMd-myhwhfF_sq5nE130_assertion SIO_000772 15242878 NP134432.RAU6tza2332yk-VPGBp6ZmoXcLQ0tMd-myhwhfF_sq5nE130_provenance.
- NP134432.RAU6tza2332yk-VPGBp6ZmoXcLQ0tMd-myhwhfF_sq5nE130_assertion wasDerivedFrom lhgdn-20090331 NP134432.RAU6tza2332yk-VPGBp6ZmoXcLQ0tMd-myhwhfF_sq5nE130_provenance.
- NP134432.RAU6tza2332yk-VPGBp6ZmoXcLQ0tMd-myhwhfF_sq5nE130_assertion wasGeneratedBy ECO_0000203 NP134432.RAU6tza2332yk-VPGBp6ZmoXcLQ0tMd-myhwhfF_sq5nE130_provenance.